e-Drug3D

590

ETRETINATE

DISCONTINUED


INN
ETRETINATE

(has an active metabolite)

cas 54350-48-0
CLASS

DERMATOLOGICALS
ANTIPSORIATIC
KERATOLYTIC AGENTS

ROUTE (list)

ORAL

ATC code

D05BB01

PK parameters

Target

TARGET RETINOIC ACID RECEPTOR (RAR)
RETINOIC X RECEPTOR (RXR)

DrugCentral

Retinoic acid receptor alpha UNIPROT P10276 RARA

Retinoic acid receptor RXR-gamma UNIPROT P48443 RXRG

Download SDF file ethyl 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoate

Formula:
C23H30O3

Calculated chemical properties:

MW 354.47
NB_atoms 26
XLogP 5.65
PSA 32.883
NB_HD 0
NB_HA 3
fsp3 0.35
Lipinski(0=no;1=yes) 0

FDA
NDA 019369 (pdf not found) INN (ETRETINATE) TEGISON (ROCHE) APPROVAL= AP YEAR= 1986 NEWMOLECULARENTITY DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL